Increasing US FDA Approvals for Anticoagulant Drugs to Reflect Positively on North America Anticoagulants Market
Published: Jan 2021
The North American anticoagulants market is estimated to grow at a CAGR of 7.2% during the forecast period. An increasing approval for anticoagulants has been witnessed in the US owing to the rising incidences of heart diseases. The emerging focus on launches of generics has also been reported in the region.
Rising Demand for Novel Oral Anticoagulants (NOSCs) is Driving Indian Anticoagulants Market
Published: Jan 2021
Indian anticoagulants market is estimated to grow at a CAGR of 8.8% during the forecast period. A significant rise in the demand for novel oral anticoagulants has been witnessed owing to its demonstrated safety and efficacy in trials and Indian government initiatives to reduce the prices of NOSCs.
Significant Demand for Novel Oral Anticoagulants (NOACs) is Driving European Anticoagulants Market
Published: Jan 2021
European anticoagulants market is estimated to grow at a CAGR of 6.6% during the forecast period. A significant rise in the demand for NOACs has been reported in the region, which in turn, is accelerating the market growth. The use of novel oral anticoagulants (NOACs) is growing significantly in Europe as their advantages over older drugs including warfarin.
Significant Rise in the Incidences of CVD to Reflect Positively on Asia-Pacific Anticoagulants Market
Published: Jan 2021
Asia-Pacific anticoagulants market is estimated to grow at a CAGR of 7.8% during the forecast period. Researchers from the National Center for CVD in China have examined the prevalence and treatment of increased CVD risk in 1.7 million people from the China PEACE Million Persons Project.
Significant Growth in End-User Industries is Driving Asia-Pacific Calcium Carbonate Market
Published: Jan 2021
Asia-Pacific calcium carbonate market is estimated to grow at a CAGR of 4.1% during the forecast period. Significant growth in end-user industries such as plastics, paper, and paints and coatings industry is primarily driving the demand for calcium carbonate in the region.
Potential Applications in Plastics and Paper Industry is Driving the Global Calcium Carbonate Market
Published: Jan 2021
The global calcium carbonate market is estimated to grow at a CAGR of 3.5% during the forecast period. Significant applications of calcium carbonate in the plastics and paper industry are the major factor in driving the market growth.
COVID-19 Pandemic to Offer an Opportunity for the UK Biologics Market
Published: Jan 2021
UK biologics market is estimated to grow at a CAGR of 7.8% during the forecast period. COVID-19 pandemic is expected to offer an opportunity for market growth. In October 2020, Cobra Biologics (Cobra), a contract development and manufacturing organization (CDMO) engaged in the manufacturing of pharmaceuticals and biological materials, and Scancell Holdings plc, a developer of new immunotherapies to treat infectious disease and cancer, declared that they have entered into a partnership agreement in which Cobra will produce Scancell’s COVID-19 vaccine.
Significant Prevalence of Autoimmune Diseases is Reflecting Positively on the North American Biologics Market
Published: Jan 2021
North American biologics market is estimated to grow at a CAGR of 8.4% during the forecast period. As per the data published by the National Institutes of Health in 2017, nearly 23.5 million Americans (over 7% of the population) suffer from an autoimmune disease.
Rising Launches of New Biologics is Driving Indian Biologics Market
Published: Jan 2021
Indian biologics market is estimated to grow at a CAGR of 10.2% during the forecast period. A significant rise in the launches of biologics is supporting to drive market growth. For instance, in October 2020, Cadila Pharmaceuticals revealed two similar biologics in India, which include Cadalimab and NuPTH.
Rising Prevalence of Chronic Diseases is Driving European Biologics Market
Published: Jan 2021
European biologics market is estimated to grow at a CAGR of 7.9% during the forecast period. Rising incidences of chronic diseases are reflecting positively on the European biologics market. A significant rise in the prevalence of cancer and autoimmune diseases is supporting to drive market growth.